The observation that degradation of STAT3 in donor T cells by in vitro culture with STAT3 degrader SD-36 prevented acute GVHD has demonstrated the translational potential of approaches that specifically target STAT3 in donor T cells to prevent GVHD while preserving GVL activity. This evidence concerns the gene STAT3 and graft versus host disease.